Pistoia Alliance on why 69% of life sciences firms can’t measure AI’s impact, and the architectural shift that could change that

Over the past few years, consulting firms and vendors have urged life science organizations to reinvent their operations with generative AI and, more recently, with semi-autonomous agents. A February 2026 Pharmaphorum analysis by NVIDIA’s David Ruau predicted that AI scientists would become “essential collaborators” embedded across the research lifecycle as 2026 progresses. The transition remains… The post Pistoia Alliance on why 69% of life sciences firms can’t measure AI’s impact, and the arch